The DOI matches its Crossref record; 48 of the 50 references it cites were found in a registry or an index.
Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis
Abstract
Multiple sclerosis lesion activity concurs with the extent of inflammation, demyelination and axonal suffering. Pro-inflammatory myeloid cells contribute to lesion development, but the self-limiting nature of lesions implies as yet unidentified anti-inflammatory mechanisms. We addressed the hypothesis that myelin ingestion by myeloid cells induces a foamy appearance and confers anti-inflammatory function. First, we show that myelin-containing foam cells in multiple sclerosis lesions consistently express a series of anti-inflammatory molecules while lacking pro-inflammatory cytokines. Second, unique location-dependent cytokine and membrane receptor expression profiles imply functional specialization allowing for differential responses to micro-environmental cues. A novel human in vitro model of foamy macrophages functionally confirmed that myelin ingestion induces an anti-inflammatory programme. Foamy macrophages are unable to respond to prototypical inflammatory stimuli but do express molecules involved in suppression of inflammation. These findings provide novel insights into the mechanisms of lesion control and may open new roads to intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Here we show that TREM2 was highly expressed within active MS lesions by lipid-laden microglia/macrophages known to display an alternatively activated M2 profile and to promote the resolution of inflammation and clearance of myelin debris [5].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lesions with foamy microglia exhibited increased cholesterol esters (CEs) and triacylglycerols (TAG), consistent with their lipid-laden phenotype, which was confirmed by the neutral lipid staining Oil Red O (ORO)14,16”
From Foamy microglia link oxylipins to disease progression in multiple sclerosis (2026) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This lack of classical pro-inflammatory signaling has been previously found in MS lesions by mass cytometry of microglia49 and matches the lipid-induced lysosomal phenotype described in other diseases14,18,50,51.”
From Foamy microglia link oxylipins to disease progression in multiple sclerosis (2026) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which may potentially reflect metabolic reprogramming associated with the chronic nature of the lesion14,18,50.”
From Foamy microglia link oxylipins to disease progression in multiple sclerosis (2026) · cites this paper as [14]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, foamy microglia/macrophages have also been described as anti-inflammatory or immunosuppressed14,18.”
From Foamy microglia link oxylipins to disease progression in multiple sclerosis (2026) · cites this paper as [14]
The cited source says what the claim attributes to it.
In the citing paper
“lipid-laden microglia/macrophages are immunosuppressive (20)”
From Reduced Angiopoietin-Like 4 Expression in Multiple Sclerosis Lesions Facilitates Lipid Uptake by Phagocytes via Modulation of Lipoprotein-Lipase Activity (2019) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
The many faces of macrophage activation
Mosser, D. M. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0602325 · Cited by 1,902
MYELINATION IN RAT BRAIN: METHOD OF MYELIN ISOLATION1
Norton, W. T., & Poduslo, S. E. (1973) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1973.tb07519.x · Cited by 1,413
Prostaglandins as modulators of immunity
Harris, S. G., Padilla, J., Koumas, L., Ray, D. M., & Phipps, R. P. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02154-8 · Cited by 1,168
Reciprocal regulation of inflammation and lipid metabolism by liver X receptors
Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J., & Tontonoz, P. (2003) · Nature Medicine · doi:10.1038/nm820 · Cited by 1,158
Anti-inflammatory lipid mediators and insights into the resolution of inflammation
Lawrence, T., Willoughby, D. A., & Gilroy, D. W. (2002) · Nature reviews. Immunology · doi:10.1038/nri915 · Cited by 879
Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis
Greter, M., Heppner, F. L., Lemos, M. P., Odermatt, B. M., Goebels, N., Laufer, T., Noelle, R. J., & Becher, B. (2005) · Nature Medicine · doi:10.1038/nm1197 · Cited by 862
Flagged first, then by citations
2 of the 50 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Chayen J, Bitensky L. Analysis of chemical components of cells and tissues; reactions for lipids. In: Practical histochemistry. Chichester: Wiley; 1991. p. 45.
Cited by
Sorted by citations
Items 201–300 of 357
Restoring immune suppression in the multiple sclerosis brain
Koning, N., Uitdehaag, B. M. J., Huitinga, I., & Hoek, R. M. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.09.005 · Cited by 28
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters
Sexton, M., Cudaback, E., Abdullah, R. A., Finnell, J. S., Mischley, L. K., Rozga, M., Lichtman, A. H., & Stella, N. (2014) · Inflammopharmacology · doi:10.1007/s10787-014-0214-z · Cited by 28
Yao, F., Luo, Y., Chen, Y., Li, Y., Hu, X., You, X., Li, Z., Yu, S., Tian, D., Zheng, M., et al. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01203-w · Cited by 27
Bozic, I. D., Tesovic, K., Laketa, D., Adžić, M., Jakovljevic, M., Bjelobaba, I. M., Savić, D. Z., Nedeljković, N., Peković, S., & Lavrnja, I. C. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2509-8 · Cited by 27
Zhang, C., Zhao, S., Huang, Z., Ao, X., Liu, H., Dai, S., Zheng, Z., Li, Y., Guo, X., Gu, J., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103469 · Cited by 28
Bahbouhi, B., Pettré, S., Berthelot, L., Garcia, A., Ngono, A. E., Degauque, N., Michel, L., Wiertlewski, S., Lefrère, F., Meyniel, C., et al. (2010) · Brain · doi:10.1093/brain/awq074 · Cited by 25
van Eijk, M., Aust, G., Brouwer, M. S. M., van Meurs, M., Voerman, J. S. A., Dijke, E., Pouwels, W., Sändig, I., Wandel, E., Aerts, J. M. F. G., et al. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.02.004 · Cited by 25
Self-citationKamermans, A., Rijnsburger, M., Chakraborty, A., van der Pol, S., de Vries, H. E., & van Horssen, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00950 · Cited by 25
Browne, R. W., Jakimovski, D., Ziliotto, N., Kühle, J., Bernardi, F., Weinstock‐Guttman, B., Zivadinov, R., & Ramanathan, M. K. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.06.003 · Cited by 24
Boelen, A., Mikita, J., Boiziau, C., Chassande, O., Fliers, E., & Petry, K. G. (2009) · Thyroid · doi:10.1089/thy.2009.0228 · Cited by 24
Metabolic Dysfunction and Peroxisome Proliferator-Activated Receptors (PPAR) in Multiple Sclerosis
Ferret-Sena, V., Capela, C., & Sena, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061639 · Cited by 24
Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis
Schnaars, M. (2011) · doi:10.53846/goediss-919 · Cited by 25
Davies, C. L., & Miron, V. E. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.06.016 · Cited by 24
Decreased Neuro‐Axonal Proteins in CSF at First Attack of Suspected Multiple Sclerosis
Stoop, M. P., Runia, T. F., Stingl, C., de Vries, R. M. V. D. V., Luider, T. M., & Hintzen, R. Q. (2017) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201700005 · Cited by 23
Self-citationZhang, G., Yao, Q., Long, C., Yi, P., Song, J., Wu, L., Wan, W., Rao, X., Lin, Y., Wei, G., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01508 · Cited by 25
Standiford, M. M., Grund, E. M., & Howe, C. L. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02360-3 · Cited by 23
Chang, C., Lee, Y., Leu, S., Wang, C.-Y., Wei, C., Hung, K.-S., Pai, M.-H., Tsai, M., & Wu, C. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.11.050 · Cited by 22
Veroni, C., Serafini, B., Rosicarelli, B., Fagnani, C., Aloisi, F., & Agresti, C. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00190 · Cited by 21
Ozsvár, A., Szipöcs, R., Ozsvár, Z., Baka, J., Barzó, P., Tamás, G., & Molnár, G. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.01.003 · Cited by 24
Sobel, R. A., & Moore, G. W. (2008) · CRC Press eBooks · doi:10.1201/b13319-21 · Cited by 22
Differential transcriptional response profiles in human myeloid cell populations
Healy, L. M., Perron, G., Won, S., Rao, V. T. S., Guiot, M., Moore, C. S., Bar‐Or, A., & Antel, J. P. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.04.006 · Cited by 22
Visceral and Subcutaneous Abdominal Fat Predict Brain Volume Loss at Midlife in 10,001 Individuals
Raji, C. A., Meysami, S., Hashemi, S., Garg, S., Akbari, N., Gouda, A., Chodakiewitz, Y. G., Nguyen, T. D., Niotis, K., Merrill, D. A., et al. (2023) · Aging and Disease · doi:10.14336/ad.2023.0820 · Cited by 22
Bénardais, K., Gudi, V., Gai, L., Nessler, J. N., Singh, V., Prajeeth, C. K., Skripuletz, T., & Stangel, M. (2014) · Glia · doi:10.1002/glia.22706 · Cited by 19
miRNAs in Microglia: Important Players in Multiple Sclerosis Pathology
Walsh, A. D., Nguyen, L., & Binder, M. D. (2021) · ASN NEURO · doi:10.1177/1759091420981182 · Cited by 23
Ziliotto, N., Bernardi, F., Jakimovski, D., Baroni, M., Bergsland, N., Ramasamy, D. P., Weinstock‐Guttman, B., Zamboni, P., Marchetti, G., Zivadinov, R., et al. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.07.009 · Cited by 20
Wang, X., Cheng, Z., Tai, W., Shi, M., Ayazi, M., Liu, Y., Sun, L. J., Yu, C., Fan, Z., Bin, G., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.04.013 · Cited by 19
Borggrewe, M., Kooistra, S. M., Wesseling, E. M., Gierschek, F. L., Brummer, M. L., Nowak, E. C., Medeiros-Furquim, T., Otto, T. A., Lee, S. W., Noelle, R. J., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01186-7 · Cited by 20
Self-citationVenkatasubramanian, S., Tripathi, D., Tucker, T. A., Paidipally, P., Cheekatla, S. S., Welch, E., Raghunath, A., Jeffers, A., Tvinnereim, A., Schechter, M., et al. (2015) · European Journal of Immunology · doi:10.1002/eji.201545817 · Cited by 19
Myelin ingestion alters macrophage antigen-presenting function in vitro and in vivo
van Zwam, M., Samsom, J. N., Nieuwenhuis, E. E. S., Melief, M., Wierenga‐Wolf, A. F., Dijke, E., Talens, S., van Meurs, M., Voerman, J. S. A., Boven, L. A., et al. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.1209813 · Cited by 19
Self-citationDeciphering the heterogeneity of myeloid cells during neuroinflammation in the single‐cell era
Borst, K., & Prinz, M. (2020) · Brain Pathology · doi:10.1111/bpa.12910 · Cited by 17
Schoderboeck, L., Adzemovic, M. Z., Nicolussi, E.-M., Crupinschi, C., Hochmeister, S., Fischer, M.-T., Lassmann, H., & Bradl, M. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.05.026 · Cited by 19
Engelenburg, H. J., van den Bosch, A. M. R., Chen, J. Q. A., Hsiao, C., Melief, M., Harroud, A., Huitinga, I., Hamann, J., & Smolders, J. (2025) · iScience · doi:10.1016/j.isci.2025.112430 · Cited by 18
Neuro-immune crosstalk in depressive symptoms of multiple sclerosis
Wang, C., Zhou, Y., & Feinstein, A. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106005 · Cited by 20
Goldberg, G., Coelho, L. B. V., Mo, G., Adang, L. A., Patne, M., Chen, Z., García-Bassets, I., Mesci, P., & Muotri, A. R. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02348-w · Cited by 20
Sarkar, S. K., Willson, A. M. L., & Jordan, M. A. (2024) · Journal of Immunology Research · doi:10.1155/2024/5383099 · Cited by 19
Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions
Große-Veldmann, R., Becker, B., Amor, S., van der Valk, P., Beyer, C., & Kipp, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9420-y · Cited by 18
Self-citationBlandford, S. N., Galloway, D. A., Williams, J. B., Arsenault, S. T., Brown, J. E., MacLean, G., Moore, G. R. W., Barron, J., Ploughman, M., Clift, F., et al. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103006 · Cited by 16
Pathological Heterogeneity of Idiopathic Central Nervous System Inflammatory Demyelinating Disorders
Lucchinetti, C. F. (2007) · Current topics in microbiology and immunology · doi:10.1007/978-3-540-73677-6_2 · Cited by 18
Distinct transcriptional changes distinguish efficient and poor remyelination in multiple sclerosis
Chen, J. Q. A., McNamara, N. B., Engelenburg, H. J., Jongejan, A., Wever, D. D., Hopman, K., van Rixel, E., Nijhuis, P. J. H., de Winter, F., Moerland, P. D., et al. (2025) · Brain · doi:10.1093/brain/awae414 · Cited by 17
Inflammation-related alterations of lipids after spinal cord injury revealed by Raman spectroscopy
Tamošaitytė, S., Galli, R., Uckermann, O., Sitoci-Ficici, K. H., Koch, M. K., Later, R., Schackert, G., Koch, E., Steiner, G. R., & Kirsch, M. (2016) · Journal of Biomedical Optics · doi:10.1117/1.jbo.21.6.061008 · Cited by 17
Meningeal Foam Cells and Ependymal Cells in Axolotl Spinal Cord Regeneration
Enos, N., Takenaka, H., Scott, S., Salfity, H., Kirk, M. P., Egar, M., Sarria, D. A., Slayback, D. L., Belecky‐Adams, T. L., & Chernoff, E. A. G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02558 · Cited by 17
Ghazi‐Visser, L., Laman, J. D., Nagel, S., van Meurs, M., van Riel, D. A. J., Tzankov, A., Frank, S., Adams, H., Wolk, K., Terracciano, L., et al. (2013) · The FASEB Journal · doi:10.1096/fj.13-228809 · Cited by 17
Self-citationYu, S., Cheng, L., Tian, D., Li, Z., Yao, F., Luo, Y., Liu, Y., Zhu, Z., Zheng, M., & Jing, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.729524 · Cited by 16
Efficacy and tolerability of folate-aminopterin therapy in a rat focal model of multiple sclerosis
Elo, P., Li, X., Liljenbäck, H., Gardberg, M., Moisio, O., Miner, M. W. G., Virta, J., Saraste, A., Srinivasarao, M., Pugh, M. R., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02073-7 · Cited by 17
Kashani, N., Kelland, E. E., Vajdi, B., Anderson, L. M., Gilmore, W., & Lund, B. T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.706278 · Cited by 16
Pan, J., Forés-Martos, J., Nouh, C. D., Jensen, T. D., Vallejo, K., Cayrol, R., Ahmadian, S. S., Ashley, E. A., Greicius, M. D., & Cobos, I. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01853-5 · Cited by 16
Sestito, C., Brevé, J. J. P., van Eggermond, M. C. J. A., Killestein, J., Teunissen, C. E., van Rossum, J., Wilhelmus, M. M. M., Drukarch, B., van den Elsen, P. J., & van Dam, A. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-1035-y · Cited by 16
Picone, P., Palumbo, F. S., Federico, S., Pitarresi, G. L., Adamo, G., Bongiovanni, A., Chaves-Sanjuán, A., Cancemi, P., Muccilli, V., Giglio, V., et al. (2021) · Materials Today Bio · doi:10.1016/j.mtbio.2021.100146 · Cited by 15
Neuroinflammation responses and neurodegeneration in multiple sclerosis
Nataf, S. (2009) · Revue Neurologique · doi:10.1016/j.neurol.2009.09.012 · Cited by 15
Loix, M., Vanherle, S., Bolkaerts, L., Verberk, S. G. S., Punt, M., Wouters, F., Moonen, B., Verhagen, R. F. M., van Wouw, S. A. E., Jongejan, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62053-w · Cited by 16
Role of the Peripheral Nervous System in PD Pathology, Diagnosis, and Treatment
Ma, C., Zhang, W., & Cao, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.598457 · Cited by 15
Haanstra, K. G., Wubben, J. A. M., Jonker, M., & Hart, B. A. ‘. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071549 · Cited by 14
CNS macrophage contributions to myelin health
Hoffmann, A., & Miron, V. E. (2024) · Immunological Reviews · doi:10.1111/imr.13416 · Cited by 13
van Wageningen, T. A., Antonovaité, N., Paardekam, E. J., Brevé, J. J. P., Iannuzzi, D., & van Dam, A. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02134-x · Cited by 12
Bolton, C., & Smith, P. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527314666150716103629 · Cited by 14
Sestito, C., Brevé, J. J. P., Bol, J. G. J. M., Wilhelmus, M. M. M., Drukarch, B., & van Dam, A. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155024 · Cited by 15
Inhibition of CD36 ameliorates mouse spinal cord injury by accelerating microglial lipophagy
Wang, B., Du, A., Chen, X., Huang, T., Mamun, A. A., Li, P., Du, S., Feng, Y.-Z., Jiang, L.-Y., Xu, J., et al. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01463-w · Cited by 13
Inflammation alters myeloid cell and oligodendroglial iron-handling in multiple sclerosis
Riedl, C. J., Bormann, D., Steinmaurer, A., Novak, A., Testa, G., Poldlehner, E., Haider, C., Berger, T., Mildner, M., Höftberger, R., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02020-0 · Cited by 12
Elevated phagocytic capacity directs innate spinal cord repair
Shaw, D. K., Saraswathy, V. M., McAdow, A. R., Zhou, L., Park, D., Mote, R. D., Saini, A., Douthitt, A. J., Stepankova, K., Unverzagt, B., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117482 · Cited by 12
Microglia and Multiple Sclerosis
Hammond, B. P., Panda, S. P., Kaushik, D. K., & Plemel, J. R. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_25 · Cited by 11
The release of cytokines by macrophages is not affected by myelin ingestion
Glim, J. E., Vereyken, E. J. F., Heijnen, D. A. M., García-Vallejo, J. J., & Dijkstra, C. D. (2010) · Glia · doi:10.1002/glia.21062 · Cited by 11
Myelin ingestion by macrophages promotes their motility and capacity to recruit myeloid cells
van Zwam, M., Wierenga‐Wolf, A. F., Melief, M., Schrijver, B., Laman, J. D., & Boven, L. A. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.04.021 · Cited by 11
Self-citationA peptide targeting inflammatory CNS lesions in the EAE rat model of multiple sclerosis
Boiziau, C., Nikolski, M., Mordelet, E., Aussudre, J., Vargas-Sanchez, K., & Petry, K. G. (2018) · Inflammation · doi:10.1007/s10753-018-0748-0 · Cited by 10
Macrophage polarization and future perspectives: a comprehensive review
Chowdary, Y. Y., Patil, M. M., & Raghu, A. V. (2024) · Discover Materials · doi:10.1007/s43939-024-00133-2 · Cited by 10
Role of liver X receptor in multiple sclerosis: A long furtive life behind a barrier
Abulaban, A. A., Al-Kuraishy, H. M., Al-Gareeb, A. I., Ahmed, E., Fawzy, M. N., Alruwaili, M., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111333 · Cited by 10
Petry, K. G., Brochet, B., Dousset, V., Vignes, J. R., & Boiziau, C. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0432-5 · Cited by 10
Tissue-specific features of microglial innate immune responses
Timmerman, R., Burm, S. M., & Bajramovic, J. J. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104924 · Cited by 10
Chrobok, N. L., Bol, J. G. J. M., Wilhelmus, M. M. M., Drukarch, B., & van Dam, A. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz030 · Cited by 12
Foamy microglia link oxylipins to disease progression in multiple sclerosis
van der Vliet, D., Di, X., Shamorkina, T. M., Coulon-Bainier, C., Pavlovic, A., van der Vliet, I. A. C. M., Zeng, Y., Macnair, W., van Egmond, N., Chen, J. Q. A., et al. (2026) · Nature Neuroscience · doi:10.1038/s41593-026-02302-3 · Cited by 9
Plasma Lipoproteins in Brain Inflammatory and Neurodegenerative Diseases
Sena, A., Capela, C., Nóbrega, C., Ferret-Sena, V., Campos, E., & Pedros, R. (2012) · InTech eBooks · doi:10.5772/51268 · Cited by 9
Autoantibodies and their potential roles in diseases of the nervous system
Beasley, S. J., & Greer, J. M. (2015) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12269 · Cited by 10
Impact of human myelin on the maturation and function of human monocyte-derived dendritic cells
Gredler, V., Ebner, S., Schanda, K., Forstner, M., Berger, T. G., Romani, N., & Reindl, M. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.11.003 · Cited by 9
Detection of chitinase activity by 2-aminobenzoic acid labeling of chito-oligosaccharides.
der Vlugt, K. G.-V., Bussink, A. P., Groener, J., Boot, R., & Aerts, J. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2008.09.028 · Cited by 11
Self-citationBan, Y., Dong, W., Zhang, L., Zhou, T. G., Altiti, A. S., Ali, K., Mootoo, D. R., Blaho, V. A., Hla, T., Ren, Y., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00404 · Cited by 9
Brain biodistribution of myelin nanovesicles with targeting potential for multiple sclerosis
Picone, P., Palumbo, F. S., Cancilla, F., Girgenti, A., Cancemi, P., Muccilli, V., Francesco, A. D., Cimino, M., Cipollina, C., Soligo, M., et al. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.08.016 · Cited by 8
Interleukin‐3 Modulates Macrophage Phagocytic Activity and Promotes Spinal Cord Injury Repair
Li, J., Zheng, M., Ouyang, F., Ye, J., Huang, J., Zhao, Y., Wang, J., Shan, F., Li, Z., Yu, S., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70181 · Cited by 8
Sterile innate immune mechanisms in neurodegenerative diseases
Ealy, A., Serapiglia, A. M., & Panicker, N. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.111039 · Cited by 8
The molecular pathology of neurodegenerative and psychiatric disorders
Yan, P., Deng, Y. M., Su, X., Kong, H., Zhang, Y., Li, W., & Kong, E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18677-6.00007-5 · Cited by 8
Shafit‐Zagardo, B., Sidoli, S., Goldman, J. E., DuBois, J. C., Corboy, J. R., Strittmatter, S. M., Guzik, H. M., Edema, U., Arackal, A. G., Botbol, Y. M., et al. (2023) · Cells · doi:10.3390/cells12131734 · Cited by 9
T-cell response dynamics in animal models of multiple sclerosis: implications for immunotherapies
Schreiner, B., Bailey, S. L., & Miller, S. D. (2006) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.3.1.57 · Cited by 7
Multiple Sclerosis Pathology During Early and Late Disease Phases: Pathogenic and Clinical Relevance
Lucchinetti, C. F. (2007) · Springer eBooks · doi:10.1007/978-0-387-36003-4_12 · Cited by 7
van Rossum, D., Hilbert, S., Straßenburg, S., Hanisch, U., & Brück, W. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.100 · Cited by 8
Suesca, E., Alejo, J. L. P., Bolaños, N. I., Ocampo, J., Leidy, C., & González, J. M. (2013) · Cytometry Part A · doi:10.1002/cyto.a.22305 · Cited by 7
The contribution of BTK signaling in myeloid cells to neuroinflammation
Bassani, C., Molinari, M., Romeo, V., Martinelli, V., Boschert, U., Martino, G., Muzio, L., & Farina, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1595069 · Cited by 7
Blenkle, A., Geladaris, A., & Weber, M. S. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01647-w · Cited by 6
Zanetti, S. R., & Aveldaño, M. I. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.09.014 · Cited by 6
Pathophysiology of Experimental Autoimmune Encephalomyelitis
Đenić, A., Wootla, B., Pirko, I., & Mangalam, A. K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800763-1.00011-7 · Cited by 5
Wu, S., Shen, S., Sun, W., Zhao, Y., Zhang, J., Wang, Z., Cai, W. L., Lu, Z., & Qiu, W. (2025) · The FASEB Journal · doi:10.1096/fj.202500075rr · Cited by 4
Matsuda, Y., Tanaka, M., Zhao, Y., Kakihara, S., Hoshiyama, K., Sakurai, T., Kamiyoshi, A., Ichikawa‐Shindo, Y., Kawate, H., Zhang, Y., et al. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.6.12 · Cited by 5
Zarys objawów klinicznych, leczenia oraz trudności w rozpoznawaniu choroby Gauchera
Markuszewska-Kuczyńska, A., & Machaczka, M. (2015) · Acta Haematologica Polonica · doi:10.1016/j.achaem.2015.02.009 · Cited by 4
Nuclear Receptor Control of Myeloid Cell Responses - Implications for CNS Autoimmunity
Wiendl, S. H. H. (2013) · Rheumatology Current Research · doi:10.4172/2161-1149.1000124 · Cited by 4
Tsamopoulos, N. G., Kalodimou, V. E., & Vlachos, S. (2013) · Journal of Multiple Sclerosis · doi:10.4172/2376-0389.1000103 · Cited by 4
Potentially Common Therapeutic Targets for Multiple Sclerosis and Ischemic Stroke
Paternò, R., & Chillon, J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00855 · Cited by 4
Ding, D., Zhang, L., Liu, X., Sun, C., He, J., Li, J., Gao, X., Guan, F., & Zhang, L. (2022) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2021.0123 · Cited by 4
Lewis, P. A., & Spillane, J. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811069-0.00007-0 · Cited by 4
McDonald, C., Short, M. A., Jenkin, G., & Bernard, C. C. A. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1118-9_21 · Cited by 4
Kopec, B. M., Ulapane, K. R., Moral, M. E. G., & Siahaan, T. J. (2018) · Neuromethods · doi:10.1007/978-1-4939-8946-1_2 · Cited by 4
Platelets During Myelin Repair in Multiple Sclerosis: Friend or Foe?
Rivera, F. J., Philp, A. R., Reyes, C. R., Valenzuela‐Krugmann, C., & Silva, M. E. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70268 · Cited by 4
Kuo, R., Carlson, M. L., Reyes, S. T., Nagy, S. C., Kalita, M., Alam, I. S., Malik, N., Jackson, I. M., Acosta, C., Falk, I. N., et al. (2026) · Nature Communications · doi:10.1038/s41467-025-67907-x · Cited by 3
Mulat, Y., Ren, Z., Nong, C., Fu, C. B., Huo, Y., Zhao, M., Dai, Y., Chen, C., Wang, P., Wang, R., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03756-9 · Cited by 3
Metadata
- Authors
- Boven, L. A., Van Meurs, M., Van Zwam, M., Wierenga-Wolf, A., Hintzen, R. Q., Boot, R. G., Aerts, J. M., Amor, S., Nieuwenhuis, E. E., & Laman, J. D.
- Affiliations
- Erasmus MC (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- Biomedical Primate Research Centre (NL)
- Corresponding author
- Boven, Leonie A.
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-12-19
- Volume
- 129
- Issue
- 2
- Pages
- 517-526
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2166298859
- Cited by
- 353
- References
- 50
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 19 · 2023: 13 · 2022: 17 · 2021: 26 · 2020: 20 · 2019: 21 · 2018: 25 · 2017: 13 · 2016: 21 · 2015: 29 · 2014: 28 · 2013: 17 · 2012: 11
- FWCI
- 6.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- multiple sclerosis, foam cells, anti-inflammatory macrophages, myeloid cells, demyelination, cytokine expression, cell surface receptors, in vitro macrophage model, neuroinflammation
- MeSH terms
- Brain, Cells, Cultured, Enzyme-Linked Immunosorbent Assay, Humans, Immunohistochemistry, Macrophages, Myelin Sheath, RNA, Messenger, Sialoglycoproteins, Biomarkers, Interleukin-4, Transforming Growth Factor beta, Interleukin-10, Chemokines, CC, Reverse Transcriptase Polymerase Chain Reaction, Multiple Sclerosis, Relapsing-Remitting, Interleukin 1 Receptor Antagonist Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review